Comanche Biopharma is dedicated to making pregnancies safer through innovative therapies.
Key features:
Development of investigational siRNA medicineFocus on preterm preeclampsiaCommitment to evidence-based therapiesAccessibility for all women and babiesSupport resources for patients and survivors
Transforming science to improve patient lives through targeted medicines.
Key features:
Targeted therapies developmentClinical trial advancementPrecision medicine focusExpertise in biologyWorld-class medicinal chemistry
Be Biopharma is dedicated to pioneering engineered B cell medicines for serious diseases.
Key features:
Patient-centered approachInnovative B cell therapiesFocus on serious diseasesIn vivo biologics developmentResearch and clinical trials
Innovative biotherapeutics company focused on medical dermatology.
Key features:
Once-daily applicationSteroid-free formulationIndicated for plaque psoriasisIndicated for atopic dermatitisPatient assistance programs
A biopharmaceutical company focused on providing access to affordable medicines.
Key features:
Robust manufacturing capabilitiesConsistent supply of productsFDA-compliant facilitiesGlobal network of manufacturing and R&D partnersFocus on affordability in biopharmaceuticals
Innovative biopharmaceutical company focused on developing targeted cancer therapies for children and adults.
Key features:
Accelerated drug developmentTargeted cancer therapiesFocus on pediatric and adult cancersInnovative research and development strategiesPatient-centered approach
Granata Bio is a biopharma company focused on developing innovative therapeutic solutions for women's reproductive health.
Key features:
Clinical development expertiseRegulatory compliance for reproductive health productsFocus on ovarian stimulation therapiesLuteal phase support solutionsCollaboration with patient advocacy groups
Assembly Biosciences is a biopharmaceutical company focused on developing innovative antiviral therapies for serious viral diseases.
Key features:
Development of novel antiviralsClinical programs for herpesvirusesResearch on hepatitis delta and hepatitis B virusesMicrobiome therapeutic developmentPatient-focused therapeutic advancements
A global biopharmaceutical company focused on developing innovative medicines.
Key features:
Drug discovery using genetics and genomicsClinical trials for new therapeuticsFDA-approved medicationsDevelopment of novel treatment approachesOncology program for hematologic malignancies
A focused biopharma company driving innovation in drug discovery and treatment.
Key features:
Single-cell genomicsSpatial genomicsArtificial intelligence in drug discoveryLong-acting therapies for HIVDigital biological twins and organoids
A leading research-intensive biopharmaceutical company focused on developing important medicines and vaccines.
Key features:
Research-intensive development of medicinesVaccine productionConducting clinical trialsCommitment to sustainabilityGlobal health awareness initiatives
M8 Pharmaceuticals specializes in bringing innovative medicines to Latin America through strategic partnerships.
Key features:
Partnerships with pharmaceutical companiesRegulatory support for product registrationCommercialization expertise in Latin AmericaFocus on multiple therapeutic areasLocal market knowledge and customer relationships
A clinical-stage biotech company focused on inhaled therapies for rare lung diseases.
Key features:
Targeted inhaled therapiesClinical-stage drug developmentDirect delivery to lung tissueMinimization of systemic side effectsPipeline of inhaled formulations
Merck is a global health care company focused on innovative health solutions through medicines, vaccines, and biologic therapies.
Key features:
Research and development in various medical fieldsInnovative manufacturing processesPartnerships for translating innovations into therapiesVeterinary pharmaceuticals and vaccinesHealth management solutions for animals
COUR Pharma develops targeted therapies to reprogram the immune system for autoimmune disease treatment.
Key features:
Antigen-specific treatment approachTargeting a wide range of immune-mediated diseasesFocus on restoring normal immune functionPipeline of next-generation therapiesCommitment to patient access and safety